The governance controversy surrounding CEA Industries (BNC) continues to ferment. YZi Labs has spoken out again on social media, pointing out that BNC has deliberately restricted shareholders' exercise of written consent rights by implementing a poison pill plan and amending the company's bylaws—this move essentially strengthens the board's voice, rather than protecting shareholder interests as officially claimed.

What’s more noteworthy is the clear opposition between the two parties on the token issue. BNC previously denied considering the launch of an alternative token, but YZi Labs presented evidence: BNC CEO David Namdar indeed discussed related topics in a public setting in early 2025. This asymmetry of information has led the community to question the authenticity of the official statements.

From a governance perspective, restricting shareholder power while being vague on the token issue has sparked widespread concern in the Web3 community about BNC’s decision-making transparency. Whether it’s for project stability or other motives, only time will tell.